Skip to main navigation
Skip to search
Skip to main content
Mayo Clinic Home
Home
Profiles
Departments/Divisions
Grants
Research output
Prizes
Search by expertise, name or affiliation
Clinical studies of pemetrexed and gemcitabine combinations
Alex A. Adjei
Medical Oncology
Research output
:
Contribution to journal
›
Article
›
peer-review
15
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Clinical studies of pemetrexed and gemcitabine combinations'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Medicine & Life Sciences
Pemetrexed
100%
gemcitabine
84%
Clinical Studies
52%
Urinary Bladder Neoplasms
48%
glycinamide ribonucleotide
46%
Ovarian Neoplasms
46%
Non-Small Cell Lung Carcinoma
45%
thymidylate synthase-dihydrofolate reductase
42%
Hydroxymethyl and Formyl Transferases
42%
Folic Acid Antagonists
34%
Mesothelioma
30%
Pancreatic Neoplasms
23%
Poisons
18%
Neoplasms
16%
Breast Neoplasms
16%